期刊
WORLD JOURNAL OF RADIOLOGY
卷 6, 期 7, 页码 459-470出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.4329/wjr.v6.i7.459
关键词
Ultrasound; Molecular imaging; Nanoparticles contrast agents; Nanomedicine; Theranostics; Early diagnosis; Multimodal medical imaging; Cell targeting; Drug delivery
资金
- Bando Laboratori, DD MIUR of the Italian Ministry of Instruction and Research [602/Ric/2005, DM18604]
- FESR P.O. Apulia Region, Action 1.2.4 [3Q5AX31]
- Progetto Bandiera NANOMAX ENCODER
Since the recognition of disease molecular basis, it has become clear that the keystone moments of medical practice, namely early diagnosis, appropriate therapeutic treatment and patient follow-up, must be approached at a molecular level. These objectives will be in the near future more effectively achievable thanks to the impressive developments in nanotechnologies and their applications to the biomedical field, starting-up the nanomedicine era. The continuous advances in the development of biocompatible smart nanomaterials, in particular, will be crucial in several aspects of medicine. In fact, the possibility of manufacturing nanoparticle contrast agents that can be selectively targeted to specific pathological cells has extended molecular imaging applications to non-ionizing techniques and, at the same time, has made reachable the perspective of combining highly accurate diagnoses and personalized therapies in a single theranostic intervention. Main developing applications of nanosized theranostic agents include targeted molecular imaging, controlled drug release, therapeutic monitoring, guidance of radiation-based treatments and surgical interventions. Here we will review the most recent findings in nanoparticles contrast agents and their applications in the field of cancer molecular imaging employing non-ionizing techniques and disease-specific contrast agents, with special focus on recent findings on those nanomaterials particularly promising for ultrasound molecular imaging and simultaneous treatment of cancer. (c) 2014 Baishideng Publishing Group Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据